阿法替尼增强了CAR-T细胞通过新陈代谢和命运重编程的抗瘤疗效
Yueyu Dai1,2, Yue Liu2,3, Lingna An2,3
1Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, Chongqing, China.
Journal for immunotherapy of cancer
|November 17, 2024
概括
阿法替尼 (AFA) 前期治疗增强了化学抗原受体T (CAR-T) 细胞治疗的持久性和细胞毒性. 这一策略增强了CAR-T细胞的抗瘤作用,为治疗血液性恶性瘤提供了一种新的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 化学抗原受体T (CAR-T) 细胞疗法对血液恶性瘤有希望,但患有不足的T细胞持久性,导致复发.
- 氨酸激酶抑制剂 (TKIs) 在直接抗瘤作用之外的免疫调节潜力方面得到了探索.
研究的目的:
- 研究氨酸激酶抑制剂 (TKI) 提高CAR-T细胞持久性和抗瘤功效的潜力.
- 确定特定的TKI并阐明它们在调节T细胞功能的机制.
主要方法:
- 选了50个已批准的TKI,确定了阿法替尼 (AFA) 对其增强CD62L表达和减少T细胞中反应性氧物种的能力.
- 通过信号转导和代谢分析研究了AFA的机制.
- 与CAR-T细胞共同培养的AFA,分析分化,新陈代谢和基因表达 (RNA测序).
主要成果:
- 阿法替尼 (AFA) 阻断T细胞受体 (TCR) 和PI3K-Akt-mTOR信号通路,诱导代谢重编程和调节T细胞分化.
- AFA预处理抑制了CAR-T细胞的耗尽,增强了它们的持久性和细胞毒性.
- 用AFA预处理的CAR-T细胞在白血病小鼠模型中显示出显著的抗瘤疗效.
结论:
- 阿法丁尼布 (AFA) 预治疗是一种新的策略,可以提高CAR-T细胞的抗瘤性能.
- 这种方法为开发更强效和更持久的血液癌症CAR-T细胞疗法提供了潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480